|
|
||||||||
Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD.
The parietal-frontal distribution of reductions of regional cerebral metabolic rates for glucose (rCMRglc) was studied in 32 patients with mild to severe dementia of the Alzheimer type (DAT), using positron emission tomography and fluorodeoxyglucose, and was related to patterns of neuropsychological impairment. In moderate and severe DAT patients, one frontal association region, the premotor cortex, demonstrated significant metabolic reductions equivalent to reductions in the parietal association cortex, and the ratio of parietal to premotor rCMRglc had significantly greater variance than in controls. In moderately demented patients, parietal-premotor and parietal-prefrontal metabolic ratios correlated significantly with neuropsychological impairments. Disproportionate parietal hypometabolism was associated with more impairment of verbal comprehension, calculations, visuospatial construction, and immediate visuospatial memory span. Disproportionate frontal hypometabolism was associated with more impaired verbal fluency and attention. Longitudinal follow-up of 20 of the patients showed that parietal/frontal metabolic ratios and their correlated neuropsychological patterns were stable over time, as dementia severity worsened. These results indicate that in moderate to severe DAT patients, metabolic reductions in the premotor cortex are as severe as the reductions in the parietal association cortex. Moreover, the parietal-premotor distribution of metabolic reductions is variable and related to variable patterns of cognitive impairment.
Address correspondence and reprint requests to Dr. Haxby, Laboratory of Neurosciences, NIA, Building 10, Room 12S207, National Institutes of Health, Bethesda, MD 20892.
Received February 17, 1988. Accepted for publication in final form June 22, 1988.
This article has been cited by other articles:
![]() |
A. L. Boxer, J. H. Kramer, A. -T. Du, N. Schuff, M. W. Weiner, B. L. Miller, and H. J. Rosen Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment Neurology, December 9, 2003; 61(11): 1485 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Budson, A. L. Sullivan, E. Mayer, K. R. Daffner, P. M. Black, and D. L. Schacter Suppression of false recognition in Alzheimer's disease and in patients with frontal lobe lesions Brain, December 1, 2002; 125(12): 2750 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Cook, A. F. Leuchter, M. L. Morgan, E. W. Conlee, S. David, R. Lufkin, A. Babaie, J. J. Dunkin, R. O'Hara, S. Simon, et al. Cognitive and Physiologic Correlates of Subclinical Structural Brain Disease in Elderly Healthy Control Subjects Arch Neurol, October 1, 2002; 59(10): 1612 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chantal, M. Labelle, R. W. Bouchard, C. M. J. Braun, and Y. Boulanger Correlation of Regional Proton Magnetic Resonance Spectroscopic Metabolic Changes With Cognitive Deficits in Mild Alzheimer Disease Arch Neurol, June 1, 2002; 59(6): 955 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Testa, W. W. Beatty, A. C. Gleason, D. M. Orbelo, and E. D. Ross Impaired affective prosody in AD: Relationship to aphasic deficits and emotional behaviors Neurology, October 23, 2001; 57(8): 1474 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagao, K. Murase, T. Kikuchi, M. Ikeda, A. Nebu, R. Fukuhara, Y. Sugawara, H. Miki, and J. Ikezoe Fractal Analysis of Cerebral Blood Flow Distribution in Alzheimer's Disease J. Nucl. Med., October 1, 2001; 42(10): 1446 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Laven and E. M. Bednarczyk CNS Assessment Using Functional Neuro-PET Imaging Journal of Pharmacy Practice, August 1, 2001; 14(4): 308 - 331. [Abstract] [PDF] |
||||
![]() |
P. Hogh, G. M. Knudsen, K. H. Kjaer, O. S. Jorgensen, O. B. Paulson, and G. Waldemar Single Photon Emission Computed Tomography and Apolipoprotein E in Alzheimer's Disease: Impact of the {varepsilon}4 Allele on Regional Cerebral Blood Flow J Geriatr Psychiatry Neurol, March 1, 2001; 14(1): 42 - 51. [Abstract] [PDF] |
||||
![]() |
A. L. W. Bokde, P. Pietrini, V. Ibanez, M. L. Furey, G. E. Alexander, N. R. Graff-Radford, S. I. Rapoport, M. B. Schapiro, and B. Horwitz The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease Arch Neurol, March 1, 2001; 58(3): 480 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Johnson, E. Head, R. Kim, A. Starr, and C. W. Cotman Clinical and Pathological Evidence for a Frontal Variant of Alzheimer Disease Arch Neurol, October 1, 1999; 56(10): 1233 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Teipel, H. Hampel, P. Pietrini, G. E. Alexander, B. Horwitz, E. Daley, H.-J. Moller, M. B. Schapiro, and S. I. Rapoport Region-Specific Corpus Callosum Atrophy Correlates With the Regional Pattern of Cortical Glucose Metabolism in Alzheimer Disease Arch Neurol, April 1, 1999; 56(4): 467 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Imran, R. Kawashima, S. Awata, K. Sato, S. Kinomura, S. Ono, M. Sato, and H. Fukuda Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease: correlation between neuropsychiatric evaluation and CBF images J. Neurol. Neurosurg. Psychiatry, February 1, 1999; 66(2): 228 - 232. [Abstract] [Full Text] |
||||
![]() |
M. S. Albert Cognitive and neurobiologic markers of early Alzheimer disease PNAS, November 26, 1996; 93(24): 13547 - 13551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Craig, J. L. Cummings, L. Fairbanks, L. Itti, B. L. Miller, J. Li, and I. Mena Cerebral Blood Flow Correlates of Apathy in Alzheimer Disease Arch Neurol, November 1, 1996; 53(11): 1116 - 1120. [Abstract] [PDF] |
||||
![]() |
H. Yamauchi, H. Fukuyama, K. Harada, H. Nabatame, M. Ogawa, Y. Ouchi, J. Kimura, and J. Konishi Callosal Atrophy Parallels Decreased Cortical Oxygen Metabolism and Neuropsychological Impairment in Alzheimer's Disease Arch Neurol, October 1, 1993; 50(10): 1070 - 1074. [Abstract] [PDF] |
||||
![]() |
J. L. Eberling, B. R. Reed, M. G. Baker, and W. J. Jagust Cognitive Correlates of Regional Cerebral Blood Flow in Alzheimer's Disease Arch Neurol, July 1, 1993; 50(7): 761 - 766. [Abstract] [PDF] |
||||
![]() |
G. S. Smith, M. J. de Leon, A. E. George, A. Kluger, N. D. Volkow, T. McRae, J. Golomb, S. H. Ferris, B. Reisberg, J. Ciaravino, et al. Topography of Cross-sectional and Longitudinal Glucose Metabolic Deficits in Alzheimer's Disease: Pathophysiologic Implications Arch Neurol, November 1, 1992; 49(11): 1142 - 1150. [Abstract] [PDF] |
||||
![]() |
A. Kumar, M. B. Schapiro, C. L. Grady, M. F. Matocha, J. V. Haxby, A. M. Moore, J. S. Luxenberg, P. H. S. George-Hyslop, C. D. Robinette, M. J. Ball, et al. Anatomic, Metabolic, Neuropsychological, and Molecular Genetic Studies of Three Pairs of Identical Twins Discordant for Dementia of the Alzheimer's Type Arch Neurol, February 1, 1991; 48(2): 160 - 168. [Abstract] [PDF] |
||||
![]() |
K. A. Johnson, B. L. Holman, T. J. Rosen, J. S. Nagel, R. J. English, and J. H. Growdon Iofetamine I 123 Single Photon Emission Computed Tomography Is Accurate in the Diagnosis of Alzheimer's Disease Arch Intern Med, April 1, 1990; 150(4): 752 - 756. [Abstract] [PDF] |
||||
![]() |
S. I. Rapoport Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease PNAS, May 23, 2000; 97(11): 5696 - 5698. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |